Georgian PM receives jab, urges citizens to vaccinate

Georgia's prime minister Irakli Garibashvili received his Covid-19 vaccine dose on Sunday, opting for a Pfizer jab in Tbilisi while also urging his fellow citizens to vaccinate.
The head of the government, who tested positive for the virus back in April, said his entire family had received their doses while also explaining the reason for opting for the Pfizer jab.
Garibashvili told local reporters he and his spouse decided to compare their immune performance with vaccines from different companies. The PM's wife received a Sinopharm dose earlier.
The prime minister also took the opportunity to again urge individuals to vaccinate, stressing jabs were "absolutely safe" and "rumours and lies released via various means" were "without grounds".
Vaccination "protects us from death, and this argument has no counter-points", Garibashvili said in comments to the media, appealing to citizens to "protect ourselves and our families".
So far 606,988 individuals have received jabs across Georgia, with the daily rate of doses administered standing at 23,231, Agenda.ge reported.
09.08.2021 10:01
Latest news
Latest newsSerbia’s European Integration: Prospects and Obstacles
21.Oct.2025
Ukrainian Drones Set Fire to Russia’s Largest Gas Plant, Gas Intake from Kazakhstan Suspended
20.Oct.2025
Trump and Zelensky in Washington: The Return of “Hardline Support” Policy
19.Oct.2025
Activist Margretta Mirzoyan on the Political Mood in Armenia
18.Oct.2025
Trump and Putin Prepare to Meet Ahead of Zelensky’s White House Visit: A New Phase of Diplomacy or Pressure on Kyiv?
17.Oct.2025
A Shadow over the Russian-Azerbaijani Thaw: What Lies Behind the Arrest of Former Presidential Chief of Staff Ramiz Mehdiyev?
16.Oct.2025
Russia and Syria: A New Chapter in Relations After the Coup
16.Oct.2025
NATO and EU Join Forces to Build a “Drone Wall”
15.Oct.2025
Trump: New bonds of friendship to join Armenia to Azerbaijan
14.Oct.2025
UK to lift its arms embargo on Armenia, Azerbaijan
14.Oct.2025

25 Oct 2025


